Safety

Orforglipron

Adverse-event report summary for Orforglipron, drawn from the FDA Adverse Event Reporting System (FAERS).

Total reports
5
Reports flagged serious
0

“Serious” is FAERS’s own report-level flag (e.g. death, hospitalization, or another outcome the reporter marked as serious) and does not indicate a verified or compound-caused outcome.

Most frequently reported reactions

  1. Nausea3 reports
  2. Dyspepsia2 reports
  3. Abdominal Discomfort1 reports
  4. Drug Ineffective1 reports
  5. Fatigue1 reports
  6. Headache1 reports
  7. Product Use Issue1 reports

Counts reflect the most-reported reaction terms (MedDRA preferred terms) associated with reports naming this compound. A single report can list multiple reactions, so reaction counts need not sum to the total number of reports.